Ad is loading...
JBPHF
Price
$0.29
Change
-$0.00 (-0.00%)
Updated
Feb 20 closing price
RAPT
Price
$1.05
Change
-$0.02 (-1.87%)
Updated
Nov 21 closing price
104 days until earnings call
Ad is loading...

JBPHF vs RAPT

Header iconJBPHF vs RAPT Comparison
Open Charts JBPHF vs RAPTBanner chart's image
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.00 (-0.00%)
Volume$5K
CapitalizationN/A
RAPT Therapeutics
Price$1.05
Change-$0.02 (-1.87%)
Volume$546.96K
CapitalizationN/A
JBPHF vs RAPT Comparison Chart
Loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
JBPHF vs. RAPT commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBPHF is a Buy and RAPT is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (JBPHF: $0.29 vs. RAPT: $1.05)
Brand notoriety: JBPHF and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBPHF: 100% vs. RAPT: 91%
Market capitalization -- JBPHF: $165.2M vs. RAPT: $37.41M
JBPHF [@Biotechnology] is valued at $165.2M. RAPT’s [@Biotechnology] market capitalization is $37.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBPHF’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • JBPHF’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, JBPHF is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RAPT’s TA Score shows that 3 TA indicator(s) are bullish.

  • RAPT’s TA Score: 3 bullish, 6 bearish.

Price Growth

JBPHF (@Biotechnology) experienced а 0.00% price change this week, while RAPT (@Biotechnology) price change was -17.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

RAPT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBPHF($165M) has a higher market cap than RAPT($37.4M). JBPHF YTD gains are higher at: -19.089 vs. RAPT (-95.775).
JBPHFRAPTJBPHF / RAPT
Capitalization165M37.4M441%
EBITDAN/A-113.61M-
Gain YTD-19.089-95.77520%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A97.9M-
Total DebtN/A5.12M-
TECHNICAL ANALYSIS
Technical Analysis
RAPT
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
RAPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEG18.820.88
+4.91%
Montrose Environmental Group
ICCC3.660.06
+1.67%
ImmuCell Corp
EDAP2.490.04
+1.63%
EDAP TMS SA
YUM134.221.34
+1.01%
Yum! Brands
VMI338.74-1.50
-0.44%
Valmont Industries

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
RAPT - JBPHF
79%
Closely correlated
-1.87%
AXSM - JBPHF
32%
Poorly correlated
+3.79%
PYPD - JBPHF
23%
Poorly correlated
-1.72%
FRTX - JBPHF
22%
Poorly correlated
N/A
LXRX - JBPHF
21%
Poorly correlated
-4.42%
More